Efficacy and Safety of HRS9531 Injection in Obese Subjects Without Diabetes

Clinical trial NCT05881837 · COMPLETED

Trial details

NCT number: NCT05881837
Sponsor: Fujian Shengdi Pharmaceutical Co., Ltd.
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Overweight or Obesity

Start date: 2023-06-13
Primary completion: 2024-10-13
Enrollment: 249

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.